NCT02647918View on ClinicalTrials.gov

Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Renal ImpairmentHealthy
Interventions
DRUG

Sotagliflozin

Single dose

DRUG

Sotagliflozin

2 single doses

Trial Locations (4)

32809

Lexicon Investigational Site, Orlando

33014

Lexicon Investigational Site, Miami

55114

Lexicon Investigational Site, Saint Paul

55404

Lexicon Investigational Site, Minneapolis

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY